Literature DB >> 1761701

Detection of rubella-specific immunoglobulin G: comparison of the enzyme-linked immunosorbent assay and an automated microparticle enzyme immunoassay (IMx).

I J Skurrie1, J L Head, S M Garland.   

Abstract

An automated microparticle enzyme immunoassay (IMx Rubella IgG Antibody Assay; Abbott Laboratories, North Chicago, Ill.) was compared with a conventional enzyme-linked immunosorbent assay (ELISA) for detection of rubella-specific immunoglobulin G (IgG) in 400 consecutive antenatal patients. There was complete agreement between the two tests in this population, which had a positivity rate of 99% for rubella-specific IgG antibodies. The performance of the IMx was also evaluated at the cutoff zone by assaying 64 selected antenatal serum samples with low or negative rubella antibody titers as determined by ELISA. Overall, the IMx was found to be a specific, sensitive assay for the detection of rubella-specific IgG and is virtually fully automated for easy performance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1761701      PMCID: PMC270199          DOI: 10.1128/jcm.29.8.1752-1753.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  False positive rubella virus haemagglutination inhibition reactions: occurrence and disclosure.

Authors:  G Haukenes; H Blom
Journal:  Med Microbiol Immunol       Date:  1975       Impact factor: 3.402

2.  Available rubella serologic tests.

Authors:  K L Herrmann
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

3.  Modified hemagglutination-inhibition test for rubella employing human group O erythrocytes.

Authors:  N J Schmidt; J Dennis
Journal:  Appl Microbiol       Date:  1972-03

4.  Enzyme-linked immunosorbent assay for rubella immunoglobulin G: new method for attachment of antigens to microtiter plates.

Authors:  I J Skurrie; G L Gilbert
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

5.  Evaluation of microparticle enzyme immunoassays for immunoglobulins G and M to rubella virus and Toxoplasma gondii on the Abbott IMx automated analyzer.

Authors:  L E Schaefer; J W Dyke; F D Meglio; P R Murray; W Crafts; A C Niles
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

6.  Evaluation of rubella immune status by three commercial enzyme-linked immunosorbent assays.

Authors:  P R Field; D W Ho; A L Cunningham
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

  6 in total
  3 in total

1.  Multicenter evaluation of a novel quantification method for rubella and toxoplasmosis antibodies.

Authors:  B Martens-Düring; H D Dopatka
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

2.  Comparison of novel synthetic peptide-based DETECT-RUBELLA enzyme immunoassays with Enzygnost and IMx for detection of rubella-specific immunoglobulin G.

Authors:  L Pedneault; M Zrein; L Robillard; F Landry; M Lacroix; J Joncas
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

3.  Comparison of five methods for the determination of rubella immunity.

Authors:  R L Sautter; A E Crist; L M Johnson; W D Lebar
Journal:  Infect Dis Obstet Gynecol       Date:  1994
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.